PKR, apoptosis and cancer

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 123-138

  Jagus, Rosemary ^a,b   Joshi, Bhavesh ^a   Barber, Glen N ^c  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; eIF2 ; PKR; Translational regulation

Indexed keywords

DOUBLE STRANDED RNA; INITIATION FACTOR; INTERFERON; PROTEIN SERINE THREONINE KINASE;

ALPHA CHAIN; APOPTOSIS; AUTOPHOSPHORYLATION; BREAST CARCINOMA; CANCER; CANCER INHIBITION; CELL PROLIFERATION; GENETIC TRANSCRIPTION; MAMMAL CELL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; EIF-2 KINASE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; POLY(A)-BINDING PROTEINS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; RNA-BINDING PROTEINS;

EID: 0033045295     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00136-8     Document Type: Review

References (192)

1. V.M. Pain, Initiation of protein synthesis in eukaryotic cells, Eur. J. Biochem. 236 (1996) 747-771.
2. S.D. Heys, K.G. Park, M.A. McNurlan, A.G. Calder, V. Buchan, K. Blessing, O. Eremin, P.J. Garlick, Measurement of tumor protein synthesis in vivo in human colorectal and breast cancer, Clin. Sci. 80 (1991) 587-593.
3. S.D. Heys, K.G. Park, M.A. McNurlan, R.A. Keenan, R.A. Miller, O. Eremin, P.J. Garlick, Protein synthesis rates in colon and liver: stimulation by gastrointestinal pathologies, Gut 33 (1992) 976-981.
4. J. Pruim, A.T. Willemsen, W.M. Molenaar, A. van Waarde, A.M. Paans, M.A. Heesters, K.G. Go, G.M. Visser, E.J. Franssen, W. Vaalburg, Brain tumors: L-[1-C-11] tyrosine PET for visualization and quantification of protein synthetic rate, Radiology 197 (1995) 221-226.
5. W.J. Koh, T.W. Griffin, J.S. Rasey, G.E. Laramore, Positron emission tomography: a new tool for characterization of malignant disease, Acta Oncol. 33 (1994) 323-327.
6. J.A. Glaspy, R. Hawkins, C.K. Hoh, M.E. Phelps, Use of positron emission tomography in oncology, Oncology 7 (1993) 41-52.
7. C.P. Stanners, M.E. Adams, J.L. Harkins, J.W. Pollard, Transformed cells have lost control of ribosome number through the cell cycle, J. Cell Physiol. 100 (1979) 127-138.
8. R.E. Rhoads, Protein synthesis, cell growth and oncogenesis, Curr. Opin. Cell Biol. 3 (1991) 1019-1024.
9. N. Sonenberg, Translation factors as effectors of cell growth and tumorigenesis, Curr. Opin. Cell Biol. 5 (1993) 955-960.
10. N. Sonenberg, Regulation of translation and cell growth by eIF4E, Biochimie 76 (1994) 839-846.
11. C. Kevil, P. Cater, B. Hu, A. DeBenedetti, Translational enhancement of FGF-2 by eIF4 factors, and alternate utilization of CUG and AUG codons for translational initiation, Oncogene 11 (1995) 2339-2348.
12. N. Sonenberg, eIF4E and control of cell growth, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational Control, CSHL Press, Cold Spring Harbor, 1996.
13. B. Raught, A.-C. Gingras, A. James, D. Medina, N. Sonenberg, J.M. Rosen, Expression of a translationally regulated, dominant-negative C/EBPβ isoform and upregulation of eIF2α are correlated with neoplastic transformation of mammary epithelial cells, Cancer Lett. 59 (1996) 4382-4386.
14. I.B. Rosenwald, Deregulation of protein synthesis as a mechanism of neoplastic transformation, BioEssays 18 (1996) 243-250.
15. I.B. Rosenwald, Upregulated expression of the genes encoding eIF4E and eIF2α in transformed cells, Cancer Lett. 102 (1996) 113-123.
16. C.G. Larminie, H.M. Alzuherri, C.A. Cairns, A. McLees, R.J. White, Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein, J. Mol. Med. 76 (1998) 94-103.
17. D.R. Morris, Growth control of translation in mammalian cells, Progr. Nucleic Acid Res. Mol. Biol. 51 (1995) 339-363.
18. G. Koch, J. Bilello, J. Kruppa, F. Koch, Amplification of translational control by membrane-mediated events, Ann. NY Acad. Sci. 339 (1980) 280-306.
19. J.M. Bishop, Molecular themes in oncogenesis, Cell 64 (1991) 235-238.
20. R.A. Weinberg, Oncogenes and tumor suppressor genes, CA Cancer J. Clin. 44 (1994) 160-170.
21. M. Kozak, An analysis of vertebrate mRNA sequences: intimations of translational control, J. Cell Biol. 115 (1991) 887-903.
22. A. Flynn, C.G. Proud, The role of eIF4 in cell proliferation, Cancer Surv. 27 (1996) 293-310.
23. L.F. Steel, D.L. Telly, J. Leonard, B.A. Rice, B. Monks, J.A. Sawicki, Elements in the murine c-mos messenger RNA 5′-untranslated region repress translation of downstream coding sequences, Cell Growth Differ. 7 (1996) 1415-1424.
24. S. Vagner, M.C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, A.C. Prats, Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes, Mol. Cell. Biol. 15 (1995) 35-44.
25. J. Bernstein, I. Shefler, O. Elroy-Stein, The translational repression mediated by the platelet-derived growth factor 2/c-sis mRNA leader is relieved during megakaryocytic differentiation, J. Biol. Chem. 270 (18) (1995) 10559-10565.
26. J. Bernstein, O. Sella, S.Y. Le, O. Elroy-Stein, PDGF2/ c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES), J. Biol. Chem. 272 (1997) 9356-9362.
27. L.M. Shantz, R.H. Hu, A.E. Pegg, Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E, Cancer Res. 56 (1996) 3265-3269.
28. L. Hengst, R.S. I, Translational control of p27Kip1 accumulation during the cell cycle, Science 271 (1996) 1861-1864.
29. M.E. Ewen, S.J. Miller, p53 and translational control, Biochim. Biophys. Acta 1242 (1996) 181-184.
30. M.E. Ewen, p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest, J. Lab. Clin. Med. 128 (1996) 355-360.
31. M. Tatsuka, H. Mitsui, M. Wada, A. Nagata, H. Nojima, H. Okayama, Elongation factor-1 alpha gene determines susceptibility to transformation, Nature 359 (1992) 333-336.
32. A. DeBenedetti, R.E. Rhoads, Overexpression of eIF-4E in HeLa cells results in aberrant growth and morphology, Proc. Natl. Acad. Sci. 87 (1990) 8212-8216.
33. A.E. Koromilas, S. Roy, G.N. Barber, M. Katze, N. Sonenberg, Malignant transformation by a mutant of the INF-inducible dsRNA-dependent protein kinase, Science 257 (1992) 1685-1689.
34. T. Fukuchi-Shimogori, I. Ishii, K.H.M. Kashiwagi, H. Ekimoto, K. Igarashi, Malignant transformation by overproduction of translation initiation factor eIF4G, Cancer Res. 57 (1997) 5041-5044.
35. O. Donze, R. Jagus, A.E. Koromilas, J.W.B. Hershey, N. Sonenberg, Abrogation of translation initiation factor eIF-2 phosphorylation, EMBO J. 14 (1995) 3828-3834.
36. C.J. Kho, H. Zarbl, Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria, Proc. Natl. Acad. Sci. 15 (1992) 2200-2204.
37. C.J. Kho, Y. Wang, H. Zarbl, Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation, Cell Growth Differ. 7 (1996) 1157-1166.
38. V. Kerekatte, K. Smiley, B. Hu, A. Smith, F. Gelder, A. DeBenedetti, The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas, Int. J. Cancer 64 (1995) 27-31.
39. B.D. Li, L. Liu, M. Dawson, A. DeBenedetti, Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma, Cancer 79 (1997) 2385-2390.
40. K. Asano, W.C. Merrick, J.W. Hershey, The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome, J. Biol. Chem. 272 (1997) 23477-23480.
41. B.T. Edmonds, J. Wyckoff, Y.G. Yeung, Y. Wang, E.R. Stanley, J. Jones, J. Segall, J. Condeelis, Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma, J. Cell Sci. 109 (1996) 2705-2714.
42. J. Condeelis, Elongation factor 1 alpha, translation and the cytoskeleton, Trends Biochem. Sci. 20 (1995) 169-170.
43. K. Chi, D.V. Jones, M.L. Frazier, Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon, Gastroenterology 103 (1992) 98-102.
44. B. Ender, P. Lynch, Y.H. Kim, N.V. Inamdar, K.R. Cleary, M.L. Frazier, Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas, Mol. Carcinog. 7 (1993) 18-20.
45. S. Mathur, K.R. Cleary, N. Inamdar, Y.H. Kim, P. Steck, M.L. Frazier, Overexpression of elongation factor-1gamma protein in colorectal carcinoma, Cancer 82 (1998) 816-821.
46. K. Pogue-Geile, J.R. Geiser, M. Shu, C. Miller, I.G. Wool, A.I. Meisler, J.M. Pipas, Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein, Mol. Cell Biol. 11 (1991) 3842-3849.
47. W.C. Merrick, J.W.B. Hershey, The pathway and mechanism of eukaryotic protein synthesis, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational Control, CSHL Press: Cold Spring Harbor, 1996, pp. 31-69.
48. C. DeHaro, The eIF2α kinases and the control of protein synthesis, FASEB J. 10 (1996) 1378-1387.
49. J.W.B. Hershey, Protein phosphorylation controls translation rates, J. Biol. Chem. 264 (1989) 20823-20826.
50. R.E. Rhoads, Regulation of eukaryotic protein synthesis by initiation factors, J. Biol. Chem. 268 (1993) 3017-3020.
51. C.E. Samuel, The eIF-2α protein kinases, regulation of translation from yeasts to eukaryotes, J. Biol. Chem. 268 (1993) 7603-7606.
52. R. Jagus, M.E. Gray, Proteins that interact with PKR, Biochimie 76 (1994) 779-791.
53. M.J. Clemens, A. Elia, The double-stranded RNA-dependent protein kinase PKR: structure and function, J. Interferon Cytokine Res. 17 (1997) 503-524.
54. M.J. Clemens, PKR - a protein kinase regulated by double-stranded RNA, Int. J. Biochem. Cell. Biol. 29 (1997) 945-949.
55. E. Meurs, K. Chong, J. Galabru, N.M.K.I. Thoma, B.R.G. Williams, A.G. Hovanessian, Molecular cloning and characterization of the double-stranded, RNA-activated protein kinase induced by interferon, Cell 62 (1990) 379-390.
56. M.G. Katze, D. Decorato, B. Safer, J. Galabru, A.G. Hovanessian, Adenovirus VAI RNA complexes with p68 kinase to regulate its autophosphorylation and activity, EMBO J. 6 (1987) 689-697.
57. M.B. Mathews, Viral evasion of cellular defense mechanisms: regulation of DAI by RNA effectors, Semin. Virol. 4 (1993) 247-257.
58. A.G. Hovanessian, Double-stranded RNA-activated protein kinase induced by interferon: dsRNA-PK, J. Interferon Res. 9 (1989) 641-647.
59. D.C. Thomis, C.E. Samuel, cDNA structure, expression, and regulation of PKR from human cells, Virology 188 (1992) 33-46.
60. L.J. Baier, T. Shors, S.T. Shors, B.L. Jacobs, The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR, Nucleic Acids Res. 11 (1993) 4830-4835.
61. H. Mellor, K.M. Flowers, S.R. Kimball, L.S. Jefferson, Cloning and characterization of a cDNA encoding rat PKR, the double-stranded RNA-dependent eukaryotic initiation factor-2 kinase, Biochim. Biophys. Acta 1219 (1994) 693-696.
62. S.K. Hanks, A.M. Quinn, T. Hunter, The protein kinase family: conserved features and deduced phylogeny of catalytic domains, Science 241 (1988) 42-52.
63. S.K. Hanks, T. Hunter, Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification, FASEB J. 9 (1995) 576-596.
64. M.G. Katze, M. Wambach, M.-L. Wong, M. Garfinkel, E. Meurs, B. Williams, A.G. Hovanessian, G.N. Barber, Functional expression and RNA binding analysis of dsRNA dependent PKR in a cell-free system, Mol. Cel. Biol. 11 (1991) 5497-5505.
65. K.L. Chong, L. Feng, K. Schappert, E. Meurs, T.F. Donohue, J.D. Friesen, A.G. Hovanessian, B.R.G. Williams, Human p68 kinase (PKR) exhibits growth suppression in yeast and homology to the translational regulator, GCN2, EMBO J. 11 (1992) 1553-1562.
66. G.-S. Feng, K. Chong, A. Kumar, B.R.G. Williams, Identification of dsRNA binding domains in interferon-induced eIF-2α-PK, Proc. Natl. Acad. Sci. 89 (1992) 5447-5451.
67. R.C. Patel, G.C. Sen, Identification of dsRNA binding domain of human, interferon-inducible protein kinase, J. Biol. Chem. 267 (1992) 7871-7876.
68. S.J. McCormack, D.C. Thomis, C.E. Samuel, Mechanism of interferon action: identification of RNA binding domain within N-terminal region of the human RNA-dependent P1/eIF2 alpha kinase, PKR, Virology 188 (1992) 47-56.
69. S.R. Green, M.B. Mathews, Two RNA binding motifs in the dsRNA-activated protein kinase, DAI, Genes Develop. 6 (1992) 2478-2490.
70. D. St. Johnson, N. Brown, J.G. Gall, M. Jantsch, A conserved dsRNA binding domain, Proc. Natl. Acad. Sci. 89 (1992) 10979-10983.
71. M. Bycroft, S. Grunert, A.G. Murzin, M. Proctor, D. St. Johnston, NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal proteinS5, EMBO J. 14 (1995) 3572-3584.
72. A. Kharrat, M.J. Macias, T.J. Gibson, M. Nilges, A. Pastore, Structure of the dsRNA binding domain of E. coli RNAse III, EMBO J. 14 (1995) 3572-3584.
73. S. Zhu, P.R. Romano, R.C. Wek, Ribosome targeting of PKR is mediated by two dsRNA-binding domains and facilitates in vivo phosphorylation of eIF2, J. Biol. Chem. 272 (1997) 14434-14441.
74. A.W.B. Craig, G.P. Cosentino, O. Donze, N. Sonenberg, The kinase insert domain of interferon-induced protein kinase, PKR, is required for activity but not for interaction with the pseudosubstrate K3L, J. Biol. Chem. 271 (1996) 24526-24533.
75. M. Gale, S.L. Tan, M. Wambach, M.G. Katze, Interaction of the interferon-induced kinase, PKR, with inhibitory proteins p58 and vaccinia virus K3L is mediated by unique domains - implications for kinase function, Mol. Cell. Biol. 16 (1996) 4172-4181.
76. T.V. Sharp, J.E. Witzel, R. Jagus, A homologous region of eIF2α and vaccinia virus K3L gene product interact with the same domain in PKR, Eur. J. Biochem. 250 (1997) 85-92.
77. R. Cai, B.R.G. Williams, Mutations in the double-stranded RNA-activated protein kinase insert region that uncouple catalysis from eIF2alpha binding, J. Biol. Chem. 273 (1998) 11274-11280.
78. H.D. Robertson, M.B. Mathews, The regulation of the protein kinase PKR by RNA, Biochimie 78 (1996) 909-914.
79. D.R. Taylor, S.B. Lee, P.R. Romano, D.R. Marshak, A.G. Hinnebusch, M. Esteban, M.B. Mathews, Autophosphorylation sites participate in the activation of PKR, Mol. Cell. Biol. 16 (1996) 6295-6302.
80. P.R. Romano, M.T. Garcia-Barrio, X. Zhang, Q. Wang, D.R. Taylor, F. Zhang, C. Herring, M.B. Mathews, J. Qin, A.G. Hinnebusch, Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2, Mol. Cell. Biol. 18 (1998) 2282-2297.
81. H. Tanaka, C.E. Samuel, Structure of mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase, Proc. Natl. Acad. Sci. 91 (1994) 7995-7999.
82. C.E. Samuel, K. Ozata, Induction of interferons and interferon-induced genes, Biotherapy 8 (1996) 183-187.
83. K.L. Kuhen, X.Y. Shen, E.R. Carlisle, A.L. Richardson, H.U.G. Weier, H. Tanaka, C.E. Samuel, Structural organization of the human gene encoding PKR and differences from its mouse homolog, Genomics 36 (1996) 197-201.
84. T. Ito, R. Jagus, S. May, IL-3 stimulates protein synthesis by regulating dsRNA-dependent protein kinase (PKR), Proc. Natl. Acad. Sci. 91 (1994) 7455-7459.
85. T.G. Lee, J. Tomita, A.G. Hovanessian, M.G. Katze, Purification and partial characterization of an inhibitor of PKR during influenza virus infection, Proc. Natl. Acad. Sci. 87 (1990) 6208-6212.
86. T.G. Lee, J. Tomita, A.G. Hovanessian, M.G. Katze, Characterization and regulation of the 58 kDa cellular inhibitor of PKR, J. Biol. Chem. 267 (1992) 14238-14243.
87. T.G. Lee, M.G. Katze, Cellular inhibitors of PKR, Progr. Mol. Subcel. Biol. 14 (1993) 48-65.
88. S.J. Polyak, N. Tang, M. Wambach, G.N. Barber, M.G. Katze, The p58 cellular inhibitor complexes with the intereferon-induced dsRNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity, J. Biol. Chem. 271 (1996) 1702-1707.
89. M.G. Katze, Games viruses play: a strategic initiative against PKR, Semin. Virol. 4 (1993) 259-268.
90. J. Galabru, A.R. Hovanessian, Autophosphorylation of dsRNA-dependent protein kinase, J. Biol. Chem. 262 (1987) 15538-15544.
91. G.P. Cosentino, S. Venkatesan, F.C. Serluca, S.R. Green, M.B. Mathews, N. Sonenberg, The dsRNA-dependent protein kinase, PKR, and TAR binding protein, TRBP, form homo- and heterodimers in vivo, Proc. Natl. Acad. Sci. 92 (1995) 9445-9449.
92. R.C. Patel, P. Stanton, N.M.J. Mcmillan, B.R.G. Williams, G.C. Sen, The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo, Proc. Natl. Acad. Sci. 92 (1995) 8283-8287.
93. P.R. Romano, S.R. Green, G.N. Barber, M.B. Mathews, A.G. Hinnebusch, Structural requirements for dsRNA binding, dimerization and activation the human eIF-2 alpha kinase DAI in S. cerevisiae, Mol. Cell. Biol. 15 (1995) 365-378.
94. B.W. Carpick, V. Graziano, D. Schneider, R.K. Maitra, B.R.G. Williams, Characterization of the solution complex between the interferon-induced, dsRNA-activated protein kinase and HIV-I trans-activating region RNA, J. Biol. Chem. 272 (1997) 9510-9516.
95. L.N. Johnson, M.E. Noble, D.J. Owen, Active and inactive protein kinases: structural basis for regulation, Cell 85 (1996) 149-158.
96. R.C. Patel, P. Stanton, G.C. Sen, Specific mutations near the amino terminus of PKR differentially affect its dsRNA and dimerization properties, J. Biol. Chem. 271 (1996) 25657-25663.
97. L.G. Ortega, M.D. McCotter, G.L. Henry, S.J. McCormack, D.C. Thomis, C.E. Samuel, Biochemical and genetic evidence for the intermolecular association of PKR from human cells, Virology 215 (1996) 31-39.
98. S. Wu, R.J. Kaufman, A model for the dsRNA-dependent dimerization and activation of PKR, J. Biol. Chem. 272 (1997) 1291-1296.
99. T.V. Sharp, F. Moonan, A. Romashko, M. Wilson, R. Jagus, The vaccinia virus E3L gene product interacts with both the regulatory and substrate binding regions of PKR. Virology (in press).
100. S.L. Tan, G.M. J, M.G. Katze, Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor, Mol. Cell. Biol. 18 (1998) 2431-2443.
101. K.L. Kuhen, C.E. Samuel, Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes, Virology 227 (1997) 119-130.
102. S. Kirchhoff, A.E. Koromilas, F. Scheper, M. Grashoff, N. Sonenberg, H. Hause, IRF-1 induced growth inhibition and interferon induction requires activity of PKR, Oncogene 11 (1995) 439-445.
103. L. Beretta, M. Gabbay, R. Berger, S.M. Hanash, N. Sonenberg, Expression of PKR is modulated by IRF-1 and is reduced in 5Q-associated leukemias, Oncogene 12 (1996) 1593-1596.
104. H. Nguyen, R. Lin, J. Hiscott, Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins, Oncogene 15 (12) (1997) 1425-1435.
105. M.C. Yeung, J. Liu, A.S. Lau, An essential role for the interferon-inducible, dsRNA-activated protein kinase, PKR, in the tumor necrosis factor-induced apoptosis in U937 cells, Proc. Natl. Acad. Sci. 93 (1996) 12451-12455.
106. S. Salzberg, M. Mandelbaum, M. Zalcberg, S. Shainberg, Interruption of myogenesis by TGF-β inhibits expression and activity of myogenic-associated PKR, Exp. Cell Res. 219 (1995) 223-232.
107. T.G. Lee, N. Tang, S. Thompson, J. Miller, M.G. Katze, The 58-kDa cellular inhibitor of PKR is a member of the TPR family of proteins, Mol. Cell. Biol. 14 (1994) 2331-2342.
108. M. Gale, C.M. Blakely, D.A. Hopkins, M.W. Melville, M. Wambach, P.R. Romano, M.G. Katze, Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK, Mol. Cell. Biol. 18 (1998) 859-871.
109. M.W. Melville, W.J. Hansen, B.C. Freeman, W.J. Welch, M.G. Katze, The molecular chaperone hsp40 regulates the activity of p58, the cellular inhibitor of PKR, Proc. Natl. Acad. Sci. 94 (1997) 97-102.
110. A. Gatignol, A. Buckler-White, B. Berkhout, K.T. Jeang, Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR, Science 251 (1991) 1597-1600.
111. H. Park, M.V. Davies, J.O. Langland, H.W. Chang, Y.S. Nam, J. Tartaglia, E. Paoletti, B.L. Jacobs, R.J. Kaufman, S. Venkatesan, TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR, Proc. Natl. Acad. Sci. 24 (1994) 4713-4717.
112. M. Benkirane, C. Neuveut, R.F. Chun, S.M. Smith, C.E. Samuel, A. Gatignol, K.T. Jeang, Oncogenic potential of Tar RNA binding protein TRBP and its regulatory interaction with PKR, EMBO J. 16 (1997) 611-624.
113. R.C. Patel, G.C. Sen, PACT, a protein activator of the interferon-induced protein kinase, PKR, EMBO J. 17 (1998) 4379-4390.
114. M.K. Ray, B. Datta, A. Chakraborty, A. Chattopadhyay, S. Meza-Keuthen, N.K. Gupta, The eIF2-associated 67-kDa polypeptide (p67) plays a critical role in the regulation of protein synthesis in animal cells, Proc. Natl. Acad. Sci. 89 (1992) 539-543.
115. S.Y. Wu, A. Rehemtulla, N.K. Gupta, R.J. Kaufman, An eIF2-associated 67 kDa glycoprotein partially reverses protein synthesis inhibition by activated PKR in intact cells, Biochemistry 35 (1996) 8275-8280.
116. R. Judware, R. Petryshyn, Partial characterization of a cellular factor that regulates dsRNA-dependent eIF-2α kinase in 3T3-F442A fibroblasts, Mol. Cell. Biol. 11 (1991) 3259-3267.
117. R. Judware, P. R, Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells, J. Biol. Chem. 267 (1992) 21685-21690.
118. S. Saito, Enhancement of the interferon-induced dsRNA-dependent protein kinase by Sindbis virus infection and heat-shock stress, Microbiol. Immunol. 34 (1990) 859-870.
119. S. Saito, M. Kawakita, Inhibitor of interferon-induced dsRNA-dependent protein kinase, Microbiol. Immunol. 35 (1991) 1105-1114.
120. L.J. Mundschau, D.V. Faller, Oncogenic ras induces inhibition of PKR, J. Biol. Chem. 267 (1992) 23092-23098.
121. L.J. Mundschau, D.V. Faller, Endogenous inhibitors of PKR in normal and ras transformed cells, Biochimie 76 (1994) 792-800.
122. J. Chou, J.J. Chen, M. Gross, B. Roizman, Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5-mutants of herpes simplex virus 1, Proc. Natl. Acad. Sci. 92 (1995) 10516-10520.
123. K. Zinn, A. Keller, L.A. Whitemore, T. Maniatis, 2-aminopurine selectively inhibits the induction of β-interferon, c-fos and c-myc, Science 240 (1988) 210-213.
124. R.K. Tiwari, J. Kusari, R. Kumar, G. Sen, Gene induction by interferons and dsRNA: selective inhibition by 2-aminopurine, Mol. Cell. Biol. 8 (1988) 4289-4294.
125. A. Maran, R.K. Maitra, A. Kumar, B. Dong, W. Xiao, G. Li, B.R. Williams, P.F. Torence, R.H. Silverman, Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras, Science 265 (1994) 789-792.
126. A.G. Hovanessian, dsRNA-activated protein kinase (PKR): antiproliferative antiviral and antitumoral functions, Semin. Virol. 4 (1993) 237-245.
127. R. Petryshyn, J.-J. Chen, L. Danley, R.L. Matts, Effect of interferon on protein translation during growth stages of 3T3 cells, Arch. Biochem. Biophys. 326 (1996) 290-297.
128. R.J. Kaufman, S.P. Srivasyava, PKR: a general transducer of the cellular stress response leading to apoptosis, in: Translational Control, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, 1996.
129. G.N. Barber, J. Tomita, M. Garfinkel, E. Meurs, A.G. Hovanessian, M.G. Katze, Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed ds RNA-activated 68,000-Da protein kinase, Virology 191 (1992) 670-679.
130. T.E. Dever, R. Sripriya, J.R. McLachlin, J. Lu, J.R. Fabian, S.R. Kimball, L.K. Miller, Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2alpha kinase homolog, Proc. Natl. Acad. Sci. 95 (1998) 4164-4169.
131. O. Savinova, R. Jagus, Use of vertical slab gel isoelectric focusing and immunoblotting to evaluate steady state levels of eIF2α phosphorylation in cells, Methods 11 (1997) 419-425.
132. D.J. Hall, S.D. Jones, D.R. Kaplan, M. Whitman, B.J. Rollins, C.D. Stiles, Evidence for a novel signal transduction pathway activated by PDGF and dsRNA, Mol. Cell. Biol. 9 (1989) 1705-1713.
133. L.J. Mundschau, D.V. Faller, PDGF signal transduction through PKR: immediate early gene induction, J. Biol. Chem. 270 (1995) 3100-3106.
134. J.N. Zullo, D.V. Faller, p21 v-ras inhibits induction of c-myc and c-fos expression by PDGF, Mol. Cell. Biol. 8 (1988) 5080-5085.
135. M.K. Offerman, J. Zimring, K.H. Mellits, M.K. Hagan, R. Shaw, R.M. Medford, M.B. Mathews, S. Goodbourn, R. Jagus, Activation of PKR and induction of vascular cell adhesion molecule-1 by dsRNA in endothelial cells, Eur. J. Biochem. 232 (1995) 28-36.
136. A. Koromilas, C. Cantin, A. Craig, R. Jagus, J. Hiscott, N. Sonenberg, The interferon-inducible protein kinase, PKR, mediates the transcriptional activation of the immunoglobulin K gene, J. Biol. Chem. 270 (1995) 25426-25434.
137. Y.-L. Yang, L.F.L. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R.G. Williams, M. Aguet, C. Weissman, Deficient signaling in mice devoid of dsRNA-dependent protein kinase (PKR), EMBO J. 14 (1995) 6095-6106.
138. A. Kumar, Y.L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB, EMBO J. 16 (1997) 406-416.
139. B.R.G. Williams, The role of the dsRNA-activated protein kinase, PKR, in signal transduction, Semin. Virol. 6 (1995) 191-202.
140. A. Kumar, J. Haque, J. Lacoste, J. Hiscott, B.R.G. Williams, PKR activates transcription factor, NF-κB by phosphorylating IκB, Proc. Natl. Acad. Sci. 91 (1994) 6288-6292.
141. S.D. Der, Y.L. Yang, C. Weissman, B.R. Williams, A dsRNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis, Proc. Natl. Acad. Sci. 94 (1997) 3279-3283.
142. S.D. Der, A.S. Lau, Involvement of the double-stranded RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity, Proc. Natl. Acad. Sci. 92 (1995) 8841-8845.
143. T. Takizawa, K. Ohashi, Y. Nakanishi, Possible involvement of dsRNA-activated protein kinase in cell death by influenza virus infection, J. Virol. 70 (1996) 8128-8132.
144. S. Balachandran, N. Kim, W.-C. Yeh, T.W. Mak, K. Bhalla, G.N. Barber, Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis and employs the death signal transducer FADD. EMBO J. (in press).
145. G.K. Haines, G. Ghadge, J.A. Radosevich, Expression of p68 protein kinase as recognized by the monoclonal antibody TJ4C4 during human fetal development, Tumour Biol. 14 (1993) 95-104.
146. G.K. Haines, G.D. Ghadge, B. Thimmapaya, J.A. Radosevich, Expression of PKR (p68) recognized by the monoclonal antibody TJ4C4 in human lung neoplasms, Virchows Archiv B Cell Pathol. 62 (1992) 151-158.
147. G.K. Haines, S. Becker, G. Ghadge, M. Kies, H. Pelzer, J.A. Radosevich, Expression of PKR(p68) in squamous cell carcinoma of the head and neck region, Arch. Otolaryngol. Head Neck Surg. 119 (1993) 1142-1147.
148. G.K. Haines, G.D. Ghadge, S. Becker, M. Kies, H. Pelzer, B. Thimmapaya, J.A. Radosevich, Correlation of the expression of PKR (p68) with differentiation in head and neck squamous cell carcinoma, Virchows Archiv B Cell Pathol. 63 (1993) 289-295.
149. T. Dever, J.-J. Chen, G.N. Barber, A.M. Cigan, L. Feng, T.F. Donohue, I.M. London, M.G. Katze, A.G. Hinnebusch, Mammalian eIF-2α-PKs functionally substitute for GCN2 and stimulate GCN4 translation in yeast, Proc. Natl. Acad. Sci. 90 (1993) 4616-4620.
150. S.B. Lee, M. Esteban, The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis, Virology 199 (1994) 491-496.
151. E. Meurs, J. Galabru, G.N. Barber, M.G. Katze, A.G. Hovanessian, Interferon-induced dsRNA activated protein kinase: antiviral and antitumoral functions, Proc. Natl. Acad. Sci. 90 (1993) 232-236.
152. G. Barber, M. Wambach, S. Thompson, R. Jagus, M.G. Katze, Mutants of PKR lacking dsRNA binding domain I can act as transdominant inhibitors and induce malignant transformation, Mol. Cell. Biol. 15 (1995) 3138-3146.
153. G.N. Barber, R. Jagus, E.F. Meurs, A. Hovanessian, M.G. Katze, Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of PKR, J. Biol. Chem. 270 (1995) 17423-17428.
154. G.N. Barber, S. Thompson, T.G. Lee, T. Strom, R. Jagus, A. Darveau, M.G. Katze, The 58-kDa inhibitor of PKR is a TPR protein with oncogenic properties, Proc. Natl. Acad. Sci. 91 (1994) 4278-4282.
155. T.V. Sharp, Q. Xiao, I. Jeffrey, D.R. Gewert, M.J. Clemens, Reversal of dsRNA-induced inhibition of protein synthesis by a catalytically inactive mutant of PKR, Eur. J. Biochem. 214 (1993) 945-948.
156. S.Y. Wu, R.J. Kaufman, dsRNA binding and not dimerization correlates with the activation of PKR, J. Biol. Chem. 271 (1996) 1756-1763.
157. L.R. Benzaquen, C. Brugnara, H.R. Byers, S. Gatton-Celli, J.A. Halperin, Clotrimazole inhibits cell proliferation in vitro and in vivo, Nat. Med. 1 (1995) 534-540.
158. H. Aktas, R. Fluckiger, J.A. Acosta, J.M. Savage, S.S. Palakurthi, J.A. Halperin, Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole, Proc. Natl. Acad. Sci. 7 (1998) 8280-8285.
159. C.R. Prostko, J.N. Dholakia, M.A. Brostrom, C.O. Brostrom, Activation of PKR by depletion of endoplasmic reticulum calcium stores, J. Biol. Chem. 270 (1995) 6211-6215.
160. S.P. Srivastava, M.V. Davies, R.J. Kaufman, Calcium depletion from endoplasmic reticulum activates PKR to inhibit protein synthesis, J. Biol. Chem. 270 (1995) 16619-16624.
161. G.N. Barber, S. Edelhoff, M.G. Katze, C.M. Distecher, Chromosomal assignment of the interferon induced PKR to human chromosome 2p21 and mouse chromosome 17E2, Genomics 16 (1993) 765-767.
162. S.M. Hanash, L. Beretta, C.L. Barcroft, S. Sheldon, T.W. Glover, D. Ungar, N. Sonenberg, Mapping of the gene for PKR to chromosome region 2P21-22: a site of rearrangements in myeloproliferative disorders, Genes, Chromosomes Cancer 8 (1993) 34-37.
163. S. Basu, P. Panayiotidis, S.M. Hart, L.Z. He, A. Man, A.V. Hoffbrand, K. Ganeshaguru, Role of double-stranded RNA-activated protein kinase in human hematological malignancies, Cancer Res. 57 (1997) 943-947.
164. C. Singh, G.K. Haines, M.S. Talamonti, J.A. Radosevich, Expression of p68 (PKR) in human colon cancer, Tumor Biol. 16 (1995) 281-289.
165. O.K. Haines, R.J. Panos, P.M. Bak, T. Brown, M. Zielinski, J. Leyland, J.A. Radosevich, Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma, Tumor Biol. 19 (1998) 52-59.
166. G.K. Haines, R. Cajulis, R. Hayden, R. Duda, M. Talamonti, J.A. Radosevich, Expression of p68 (PKR) in human breast tissues, Tumor Biol. 17 (1996) 5-12.
167. O. Savinova, B. Joshi, R. Jagus, Abnormal levels and minimal activity of the dsRNA-dependent kinase, PKR, in breast carcinoma cells, Int. J. Biochem. Cell Biol. (this issue).
168. S.B. Lee, D. Rodriguez, J.R. Rodriguez, M. Esteban, The apoptosis pathway triggered by the interferon-induced protein kinase, PKR, requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases, Virology 231 (1997) 81-88.
169. K.V. Kibler, T. Shors, K.B. Perkins, C.C. Zeman, M.P. Banaszak, J. Biesterfeldt, J.O. Langland, B.L. Jacobs, dsRNA is a trigger for apoptosis in vaccinia virus-infected cells, J. Virol. 71 (1997) 1992-2003.
170. S.P. Srivastava, K.U. Kumar, R.J. Kaufman, Phosphorylation of eIF2 mediates apoptosis in response to activation of PKR, J. Biol. Chem. 273 (1998) 2416-2423.
171. B.Z. Stanger, Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95), Mol. Med. 2 (1996) 7-20.
172. G.M. Cohen, Caspases: the executioners of apoptosis, Biochem. J. 326 (1997) 1-16.
173. G. Kroemer, The proto-oncogene Bcl-2 and its role in regulating apoptosis, Nat. Med. 3 (1997) 614-620.
174. C.M. Knudson, S.J. Korsmeyer, Bcl-2 and Bax function independently to regulate cell death, Nat. Genet. 16 (1997) 358-363.
175. J.C. Reed, Double identity for proteins of the Bcl-2 family, Nature 387 (1997) 773-776.
176. D.T. Chao, S.J. Korsmeyer, BCL-2 family: regulators of cell death, Annu. Rev. Immunol. 16 (1998) 395-419.
177. S.B. Lee, Z. Melkova, W. Yan, B.R.G. Williams, A.G. Hovanessian, M. Esteban, The interferon induced dsRNA activated p68 protein kinase (PKR) potently inhibits protein synthesis in cultured cells, Virology 192 (1993) 380-385.
178. T. Takizawa, Mechanism of the induction of apoptosis by influenza virus infection, Nippon-Rinsho 54 (1996) 1836-1841.
179. K.U. Kumar, R.J. Kaufman, unpublished observations.
180. N. Wada, M. Matsumura, Y. Ohba, N. Kobayashi, T. Takizawa, Y. Nakanishi, Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection, J. Biol. Chem. 270 (1995) 18007-18012.
181. P. Descombes, U. Schibler, A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA, Cell 67 (1991) 569-579.
182. J.C. Reed, Balancing cell life and death: bax, apoptosis and breast cancer, J. Clin. Invest. 97 (1996) 2403-2404.
183. R.C. Bargou, P.T. Daniel, M.Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H.D. Royer, B. Dorken, Expression of bcl-2 family in normal and malignant breast tissue, Int. J. Cancer 60 (1995) 854-859.
184. S. Krajewski, C. Blomqvist, K. Franssila, M. Krajewska, V.M. Wasenius, E. Niskanen, S. Nordling, J.C. Reed, Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma, Cancer Res. 55 (1995) 4471-4478.
185. R.C. Bargou, C. Wagener, K. Bommert, M.Y. Mapara, P.T. Daniel, W. Arnold, P.T. Dietel, H. Guski, A. Feller, H.D. Royer, B. Dorken, Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice, J. Clin. Invest. 97 (1996) 2651-2659.
186. C. Wagener, R.C. Bargou, P.T. Daniel, K. Bommert, M.Y. Mapara, H.D. Royer, B. Dorken, Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis, Int. J. Cancer 67 (1996) 138-141.
187. M.A. Leff, D.J. Buckley, J.S. Krumenacker, J.C. Reed, T. Miyashita, A.R. Buckley, Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells, Endocrinology 137 (1996) 5456-5462.
188. K. Mengubas, F.A. Riordan, A.V. Hoffbrand, R.G. Wickremasinghe, Coordinated downregulation of bcl-2 and bax expression during granulocytic and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line, FEBS Lett. 394 (1996) 356-360.
189. A.G. Hinnebusch, Translational regulation of yeast GCN4. A window on factors that control initiator-tRNA binding to the ribosome, J. Biol. Chem. 272 (1997) 21661-21664.
190. Z.N. Oltvai, C.L. Milliman, S.J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74 (1993) 609-619.
191. T. Miyashita, J.C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell 80 (1995) 293-299.
192. M. Harigai, T. Miyashita, M. Hanada, J.C. Reed, A cis-acting element in the BCL-2 gene controls expression through translational mechanisms, Oncogene 12 (1996) 1369-1374.